Skip to Main Content

Paper Details

Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer.
Oncogene
7
2022
MAPK, NF1, NF1 mutations, NF1-mutant, NF1-mutant colorectal cancer, NF1-mutant tumors, Neurofibromin 1, PI3K, PIK3CA, PTEN mutations, RAS, bevacizumab, cetuximab, colorectal cancer, metastatic colorectal cancer, patients, wild, wild type tumors
Author NameAffiliation
Joshua MillsteinNorris Comprehensive Cancer Center, University of Southern California
Joanne XiuClinical & Translational Research
Fang-Shu OuMayo Clinic
  • 1 - 3

Datasets

Release 1.2